Bioiberica was present at the 27th congress of the SEFC, Spanish Society of Clinical Pharmacology, which was held this past weekend at Seville.
The awards, organized by the international publishing group FoodBev Media, have given recognition to the innovation that this new ingredient represents in the food industry, more precisely within the dairy sector.
This is the first DNA saliva test that predicts a patient's genetic predisposition to suffering from rapid progression knee osteoarthritis.
The award recognises the Spanish biotech firm's commitment to research and innovation and its contribution to improving the quality of life of degenerative arthritis patients.
There are 8 hereditary genetic variants associated with the rapid progression of knee osteoarthritis. One of these has been identified with the progression of osteoarthritis for the first time.